Renerva, Inc.
PrivateLast Round
Grant
Sep 24, 2019
Total Funding Raised
$3.86M
Company Overview
Renerva, Inc. operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Grant round in September 2019.
Renerva, Inc. is a medical device company that develops and commercializes implantable technologies to improve peripheral nerve repair outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renerva, Inc. Comparables
Compare Renerva, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regenity Biosciences | 79% | |
| Neuraptive Therapeutics | 78% | |
| Axogen Inc | 78% |
For institutional investors. Book with your work email.
Renerva, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2019 | ||||
| Seed | Apr 30, 2019 | ||||
| Grant | Dec 14, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Renerva, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keiretsu Forum | Seed |
| Chemical Angel Network | Seed |
| NIH RADx | Grant |
| University of Pittsburgh Investment Office | Accelerator |
| U.S. Department of War | Grant, Seed |
| Medical Technology Enterprise Consortium | Grant |
| Rochester Angel Network | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 70% MoM.
- Nov 13, 2025
Monthly visitors grew 138% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
Renerva, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Renerva, Inc.'s valuation, stock price, and market status.
Is Renerva, Inc. a public or private company?
Renerva, Inc. is a private company.
What is the current stock price of Renerva, Inc.?
Renerva, Inc. is a private company, so its shares have no public market price. Caplight tracks Renerva, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Renerva, Inc. worth (valuation)?
Valuation information for Renerva, Inc. is not publicly available.
Can I buy Renerva, Inc. stock?
Renerva, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Renerva, Inc.'s last funding round?
Renerva, Inc.'s most recent funding round was Grant on September 24, 2019.
Who are the main investors in Renerva, Inc.?
Key investors in Renerva, Inc. include Keiretsu Forum, Chemical Angel Network, NIH RADx, University of Pittsburgh Investment Office, U.S. Department of War.
Will Renerva, Inc. IPO soon?
No public IPO plans have been announced for Renerva, Inc..
How can I track Renerva, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Renerva, Inc.'s shares on secondary markets.